Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Noninvasive transcutaneous magnetic stimulation eases burden of ventricular tachycardia

Key clinical point: Transcutaneous magnetic stimulation reduced the impact of sustained ventricular tachycardia in adult men.

Major finding: Men with a history of sustained ventricular tachycardia showed significant reduction in episodes during the 48 hours after treatment with TCMS compared with the 24 hours before treatment (99 episodes vs. 5 episodes).

Study details: The data come from a case series of 5 men aged 40 to 68 years with at least 3 episodes of sustained ventricular tachycardia within 24 hours of study enrollment.

Disclosures: The study received no outside funding. Lead author Dr. Markman had no financial conflicts to disclose.

Citation:

Markman TM et al. JAMA. 2020 May 5. doi:10.1001/jama.2020.3833.